Pluri Inc. Deferred Tax Assets, Operating Loss Carryforwards
Pluri Inc. (PLUR) had Deferred Tax Assets, Operating Loss Carryforwards of $87.31 million as of 2026-06-30, per its 10-K filed 2026-09-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-09-10
- 2026-06-30: Deferred Tax Assets, Operating Loss Carryforwards $87.31M.
- 2025-06-30: Deferred Tax Assets, Operating Loss Carryforwards $82.36M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $69.56M.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards $69.85M.
- 2023-06-30: Deferred Tax Assets, Operating Loss Carryforwards $80.53M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-06-30 | $87.31M 10-K · filed 2026-09-10 | |
| 2025-06-30 | $82.36M 10-K · filed 2026-09-10 | $69.56M 10-K · filed 2025-09-17 |
| 2024-06-30 | $69.85M 10-K · filed 2025-09-17 | |
| 2023-06-30 | $80.53M 10-K · filed 2024-09-18 | |
| 2022-06-30 | $65.38M 10-K · filed 2023-09-12 | |
| 2021-06-30 | $57.30M 10-K · filed 2022-09-21 | |
| 2020-06-30 | $49.03M 10-K · filed 2021-09-13 | $11.93M 10-K · filed 2020-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |